Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT04314843 |
Title | Study of Lenzilumab and Axicabtagene Ciloleucel in Participants With Relapsed or Refractory Large B-Cell Lymphoma (ZUMA-19) |
Acronym | ZUMA-19 |
Recruitment | Terminated |
Gender | both |
Phase | Phase Ib/II |
Variant Requirements | No |
Sponsors | Kite, A Gilead Company |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Stanford University | Palo Alto | California | 94305 | United States | Details | |
Moffitt Cancer Center | Tampa | Florida | 33612 | United States | Details | |
Northwestern University | Evanston | Illinois | 60208 | United States | Details | |
Mayo Clinic | Rochester | Minnesota | 55905 | United States | Details | |
Roswell Park Cancer Institute | Buffalo | New York | 14263 | United States | Details | |
Columbia University Medical Center, New York-Presbyterian Hospital | New York | New York | 10032 | United States | Details | |
Levine Cancer Center | Charlotte | North Carolina | 28204 | United States | Details | |
Oregon Health & Science University | Portland | Oregon | 97239 | United States | Details | |
Vanderbilt University | Nashville | Tennessee | 37232 | United States | Details | |
MD Anderson Cancer Center | Houston | Texas | 77030 | United States | Details |